Skip to content

Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections

Cranberry: Interactions With Anti-Infectious Agents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00084201
Enrollment
18
Registered
2004-06-09
Start date
2006-07-31
Completion date
2007-06-30
Last updated
2006-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

Vaccinium macrocarpon

Brief summary

The purpose of study is to determine whether cranberry juice interacts with antibiotics used to treat urinary tract infections (UTIs).

Detailed description

Although evidence of its effectiveness is limited, cranberry juice is widely used to prevent urinary tract infections (UTIs). However, recent studies have shown that cranberry juice may affect the way the body absorbs and metabolizes antibiotics used to treat UTIs. This study will determine whether concurrent cranberry juice administration lowers the urinary concentrations of two commonly used antibiotics, amoxicillin and cefaclor. This study will involve children being treated for UTIs and adults without UTIs. All of the children will continue their prescribed amoxicillin/cefaclor treatment. After 7 to 10 days of antibiotic treatment, the children will be assigned to receive either cranberry juice for 2 days or no additional treatment. Urine samples will be collected from all child participants before and after the administration of cranberry juice to examine the excretion of the antibiotics. Adult participants will receive two different doses of amoxicillin, with or without cranberry juice. Blood and urine samples will be collected to evaluate the effect of cranberry juice on the absorption and elimination of amoxicillin.

Interventions

DRUGAmoxicillin

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

for Children: * Urinary tract infection (UTI) treated with cefaclor or amoxicillin Inclusion Criteria for Adults: * No UTI

Exclusion criteria

* Allergies to antibiotics * Use of medications other than oral contraceptives * Pregnancy or breast-feeding * Smoker

Design outcomes

Primary

MeasureTime frame
Drug Elmination

Secondary

MeasureTime frame
Drug absorption

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026